Placebo-controlled trial of amantadine for severe traumatic brain injury.
about
Embracing failure: What the Phase III progesterone studies can teach about TBI clinical trialsCatecholamines and cognition after traumatic brain injuryCognitive Impairment and Rehabilitation Strategies After Traumatic Brain InjuryTraumatic Axonal Injury: Mechanisms and Translational OpportunitiesIschemic long-term-potentiation (iLTP): perspectives to set the threshold of neural plasticity toward therapyMusic in Research and Rehabilitation of Disorders of Consciousness: Psychological and Neurophysiological FoundationsThe promotion of recovery through rehabilitation after acquired brain injury in childrenAmantadine ameliorates dopamine-releasing deficits and behavioral deficits in rats after fluid percussion injuryInflammation and neuroprotection in traumatic brain injuryThe Controlled Cortical Impact Model: Applications, Considerations for Researchers, and Future DirectionsHistorical Review of the Fluid-Percussion TBI ModelEmerging therapies in traumatic brain injuryThe human frontal lobes and frontal network systems: an evolutionary, clinical, and treatment perspective[Efficacy of early neurological and neurosurgical rehabilitation : Evidence-based treatment, outcome and prognostic factors].Whither the "Improvement Standard"? Coverage for Severe Brain Injury after Jimmo v. Sebelius.Amantadine alleviates postoperative cognitive dysfunction possibly by increasing glial cell line-derived neurotrophic factor in rats.Sensory Stimulation and Music Therapy Programs for Treating Disorders of ConsciousnessTechnology-based intervention programs to promote stimulation control and communication in post-coma persons with different levels of disabilityAdvanced neuroimaging in traumatic brain injuryPredicting and preventing postconcussive problems in paediatrics (5P) study: protocol for a prospective multicentre clinical prediction rule derivation study in children with concussion.Impaired consciousness in partial seizures is bimodally distributed.Chronic traumatic encephalopathy: a critical appraisal.Recent advances in disorders of consciousness: focus on the diagnosis.The Role of Neuroimaging Techniques in Establishing Diagnosis, Prognosis and Therapy in Disorders of Consciousness.Changes in cerebral metabolism in patients with a minimally conscious state responding to zolpidemNutritional support for patients sustaining traumatic brain injury: a systematic review and meta-analysis of prospective studies.Amantadine: a review of use in child and adolescent psychiatryFunctional MRI and outcome in traumatic comaDivergent long-term consequences of chronic treatment with haloperidol, risperidone, and bromocriptine on traumatic brain injury-induced cognitive deficitsConcussion is confusing us all.Tilt Table Therapies for Patients with Severe Disorders of Consciousness: A Randomized, Controlled TrialPsychotropic Medication Use During Inpatient Rehabilitation for Traumatic Brain Injury.Non-invasive brain stimulation to promote alertness and awareness in chronic patients with disorders of consciousness: Low-level, near-infrared laser stimulation vs. focused shock wave therapy.Neuroanatomic connectivity of the human ascending arousal system critical to consciousness and its disorders.Treatment of post-traumatic cognitive impairments.The effect of environmental enrichment on substantia nigra gene expression after traumatic brain injury in rats.Concussive injury before or after controlled cortical impact exacerbates histopathology and functional outcome in a mixed traumatic brain injury model in mice.Catecholaminergic based therapies for functional recovery after TBIA Narrative Review of Pharmacologic and Non-pharmacologic Interventions for Disorders of Consciousness Following Brain Injury in the Pediatric PopulationRestless Legs Syndrome in a Nigerian Elderly Population.
P2860
Q24273391-E48BB0DE-D529-47FE-A3AC-112E72BCFF16Q26743582-E82F5ADE-8C41-4477-83E6-0315AC9518D1Q26747615-8D7EB8B6-1D3B-4881-B51B-3FE7D04D050DQ26753059-475FBC7A-1DE7-4269-9A7D-3026C0D4790FQ26773846-2FB12127-EBEB-4499-A41B-1B56BBCA7289Q26774140-8184A873-96CA-4A43-A37A-62758A954AD2Q27012588-736770D5-A284-4557-8DCB-64CFA5C78BACQ27331447-202F274D-3D7F-4833-B766-D6454294DAF4Q27346247-4459B5EC-C665-460F-9ED2-F02700C1701AQ28067060-85976829-F494-4918-A0AE-89B0F29613F7Q28075670-527B4DDE-A3E0-4982-92CD-400E6923D6FEQ28087789-E24F8B24-F5F2-4B50-8AC2-91D9E7B22218Q28709470-7A6D8CE5-31E5-4CE9-B5D2-DC798E663787Q30248459-9E424FD0-1BC9-4C84-A3C2-B3E6BAA116CFQ30276680-060C9A9E-022C-437A-AA43-ED6701B5D233Q30370560-DFFCCCCB-C08F-483D-9CFA-BD5475634EEFQ30386077-55F7BC49-FA54-4816-A325-BFEAB63CADF2Q30442573-2A248F08-7D5C-49DE-BF14-38BA36AFCFEDQ30443904-5CBA2B86-323A-4577-8938-80FC9F068F77Q30542166-760D370B-3DAE-4CDB-8396-965C409610E6Q30578713-D41998F4-C4C7-4B24-A47B-6C27536C9AC1Q30688850-699E635D-2BF7-4614-9D07-99EE3607CE97Q30840987-6C3B07FB-DF78-4A38-9F3F-A912B922BD22Q31110837-C9CEE0BD-984E-4E86-BCC7-6A564B2C4BC8Q34608408-AF46618D-4222-4A41-A54E-39D665AC799CQ34634333-D93BFF4D-E8E3-4C31-B2EA-B0B5CC62625DQ34648021-9A156B7A-F2C0-4D79-B0EA-52E7C3EBE842Q34861923-EE8FBA69-3C67-41DC-ABBA-C9139190E54CQ35376749-E941CAFF-C115-46CC-8B85-6D50F8730547Q35677776-316C54E9-EA84-4BED-83E8-FDC094FCC392Q35856786-88346AB8-D57A-490D-880E-57D295D2E9A9Q35894647-3FAE5AFF-86E6-41F0-BE16-0B5E9C274954Q35990360-A05316D2-E28C-4502-98F6-5E9F3ED8E6F5Q36069908-6E0391D5-B9F8-4C4F-BFBE-7807971E773BQ36220948-67B2AC6A-E234-42C0-BC04-5D66C3CAD109Q36629436-761F44B8-A285-481C-ABA6-DE14F6B5EB24Q36672442-1D90F931-2E75-440B-9885-9C384C936334Q36909436-C863D3AB-4702-4A6E-B431-F3E8ED48F5A2Q36973315-2DFB38FC-F535-457F-9CEE-8C5A8157CF46Q37033398-566BD508-A854-4B2C-B600-6FA51BEA8F52
P2860
Placebo-controlled trial of amantadine for severe traumatic brain injury.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
Placebo-controlled trial of amantadine for severe traumatic brain injury.
@en
Placebo-controlled trial of amantadine for severe traumatic brain injury.
@nl
type
label
Placebo-controlled trial of amantadine for severe traumatic brain injury.
@en
Placebo-controlled trial of amantadine for severe traumatic brain injury.
@nl
prefLabel
Placebo-controlled trial of amantadine for severe traumatic brain injury.
@en
Placebo-controlled trial of amantadine for severe traumatic brain injury.
@nl
P2093
P356
P1476
Placebo-controlled trial of amantadine for severe traumatic brain injury.
@en
P2093
Allen Khademi
Annette Nordenbo
Bernd Eifert
David Long
Emilia Bagiella
Flora M Hammond
John Whyte
Joseph T Giacino
Kathleen Kalmar
Marianne Luther
P304
P356
10.1056/NEJMOA1102609
P407
P577
2012-03-01T00:00:00Z